Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-29

FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved Padagis US LLC's supplemental application for trospium chloride, a generic drug used to treat overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROSPIUM CHLORIDE

Snippet

SUPPL AP for TROSPIUM CHLORIDE (TROSPIUM CHLORIDE)